Research theme for competitive and other funds (2)：
2022 - 2025 骨格筋由来エクソソームによるサルコペニア合併敗血症増悪機序の解明
2018 - 2021 Strategy for the treatment of CKD-induced sarcopenia based on the crosstalk between myokine and uremic toxins
Papers (77)：
Marina Itagaki, Osamu Iketani, Yuki Enoki, Victor Tuan Giam Chuang, Kazuaki Taguchi, Shunsuke Uno, Sho Uchida, Ho Namkoong, Yoshifumi Uwamino, Yaoko Takano, et al. Analysis of Risk Factors for Developing Tuberculosis in Patients Who Received Prophylactic Latent Tuberculosis Infection Treatment with Experience of Biologic Medications. Biological & pharmaceutical bulletin. 2023. 46. 12. 1832-1837
Tatsuki Hasegawa, Sho Tashiro, Takayuki Mihara, Junya Kon, Kazuki Sakurai, Yoko Tanaka, Takumi Morita, Yuki Enoki, Kazuaki Taguchi, Kazuaki Matsumoto, et al. Efficacy of surgical skin preparation with chlorhexidine in alcohol according to the concentration required to prevent surgical site infection: meta-analysis. BJS Open. 2022. 6. 5
Masaru Samura, Yuki Kitahiro, Sho Tashiro, Hiromu Moriyama, Yuna Hamamura, Isamu Takahata, Rina Kawabe, Yuki Enoki, Kazuaki Taguchi, Yoshio Takesue, et al. Efficacy and Safety of Daptomycin versus Vancomycin for Bacteremia Caused by Methicillin-Resistant Staphylococcus aureus with Vancomycin Minimum Inhibitory Concentration > 1 μg/mL: A Systematic Review and Meta-Analysis. Pharmaceutics. 2022. 14. 4
Kana Misawa, Tomoyasu Nishimura, Shoko Kashimura, Yuki Enoki, Kazuaki Taguchi, Shunsuke Uno, Yoshifumi Uwamino, Kazuaki Matsumoto, Naoki Hasegawa. In vitro effects of diazabicyclooctane β-lactamase inhibitors relebactam and nacubactam against three subspecies of Mycobacterium abscessus complex. International journal of antimicrobial agents. 2022. 60. 5-6. 106669-106669
